Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Targeted RNA-Seq analysis of the livers of male mice treated with the perfluorinated alkyl substance PFESA-BP2 (Nafion byproduct 2)

ABSTRACT: Targeted RNA-Seq analysis of the livers of male mice treated with the perfluorinated alkyl substance PFESA-BP2 (Nafion byproduct 2)

PROVIDER: PRJNA613845 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11363468.fastq.gz	Fastqsanger.gz
	SRR11363469.fastq.gz	Fastqsanger.gz
	SRR11363470.fastq.gz	Fastqsanger.gz
	SRR11363471.fastq.gz	Fastqsanger.gz
	SRR11363472.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

Targeted RNA-Seq analysis of the livers of male mice treated with the perfluorinated alkyl substance PFESA-BP2 (Nafion byproduct 2)

Project description:The perfluorinated alkyl substance PFESA-BP2 (1,1,2,2-tetrafluoro-2-[1,1,1,2,3,3-hexafluoro-3-(1,1,2,2-tetrafluoroethoxy)propan-2-yl]oxyethane-1-sulfonic acid; also known as nafion BP2) has been detected in the blood of people living in the North Carolina Cape Fear River basin downstream of an industrial manufacturing facility. Given that almost nothing is known about the potential toxicity of PFESA-BP2 and safe exposure levels have not yet been determined, we performed a benchmark dose analysis of phenotypic and genomic effects. Male mice were exposed to PFESA-BP2 at 0, 0.03, 0.3, 3, and 6 mg/kg-day each day for 7 days by oral gavage. Transcript profiling showed that PFESA-BP2 activates a number of transcription factors linked to liver toxicity including constitutive activated/androstane receptor, pregnane X receptor, and Nrf2, but unlike other long-chain PFAS, there was only weak activation of peroxisome proliferator-activated receptor α. Steatosis was coincident with activation of sterol response element binding proteins as well as increases in the expression of the very low density lipoprotein receptor.

2022-12-01 | GSE147331 | GEO

Targeted RNA-Seq analysis of the gene expression changes in the livers of female mice treated with the perfluorinated alkyl substance PFESA-BP2 (Nafion byproduct 2)

Project description:The perfluorinated alkyl substance PFESA-BP2 (1,1,2,2-tetrafluoro-2-[1,1,1,2,3,3-hexafluoro-3-(1,1,2,2-tetrafluoroethoxy)propan-2-yl]oxyethane-1-sulfonic acid; also known as nafion BP2) has been detected in the blood of people living in the North Carolina Cape Fear River basin downstream of an industrial manufacturing facility. Given that almost nothing is known about the potential toxicity of PFESA-BP2 and safe exposure levels have not yet been determined, we performed a benchmark dose analysis of phenotypic and genomic effects. Female mice were exposed to PFESA-BP2 at 0, 0.03, 0.3, 3, and 6 mg/kg-day each day for 7 days by oral gavage. Transcript profiling showed that PFESA-BP2 activates a number of transcription factors linked to liver toxicity including constitutive activated/androstane receptor, pregnane X receptor, and Nrf2, but unlike other long-chain PFAS, there was only weak activation of peroxisome proliferator-activated receptor α. Steatosis was coincident with activation of sterol response element binding proteins as well as increases in the expression of the very low density lipoprotein receptor.

2022-12-01 | GSE147332 | GEO

Targeted RNA-Seq analysis of the gene expression changes in the livers of female mice treated with the perfluorinated alkyl substance PFESA-BP2 (Nafion byproduct 2)

Project description:Targeted RNA-Seq analysis of the gene expression changes in the livers of female mice treated with the perfluorinated alkyl substance PFESA-BP2 (Nafion byproduct 2)

| PRJNA613844 | ENA

Targeted RNA-Seq analysis of the gene expression changes in the livers of male and female mice treated with the perfluorinated alkyl substance PFESA-BP2 (Nafion byproduct 2)

Project description:Targeted RNA-Seq analysis of the gene expression changes in the livers of male and female mice treated with the perfluorinated alkyl substance PFESA-BP2 (Nafion byproduct 2)

| PRJNA614535 | ENA

Targeted RNA-Seq analysis of the gene expression changes in the livers of male and female mice treated with the perfluorinated alkyl substance PFESA-BP2 (Nafion byproduct 2)

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-12-01 | GSE147425 | GEO

Perfluorinated alkyl substances affect the growth, physiology and root proteome of hydroponically grown maize plants

Project description:Poly- and perfluorinated alkyl substances (PFAS) are a group of persistent organic pollutants. Plants can accumulate PFAS but their effect on plant physiology at the molecular level is not understood yet. We used hydroponically-grown maize plants treated with a combination of eleven different PFAS (each at 100 µg L-1) to investigate their bioaccumulation and effects on the growth, physiology and their impact on the root proteome. From the root proteome analysis, we identified 75 differentially abundant proteins, mostly involved in cellular metabolic and biosynthetic processes, translation and cytoskeletal reorganization. Results were validated using quantitative real-time PCR and further substantiated using amino acid and fatty acid profiling.

2023-02-08 | PXD029993 | Pride

Staphylococcus aureus strain:BP2

Project description:Staphylococcus aureus BP2 Genome sequencing

| PRJNA737325 | ENA

Serratia marcescens strain:BP2

Project description:Serratia marcescens strain:BP2 Genome sequencing

| PRJNA612043 | ENA

Structure-Dependent Developmental Toxicity of Alkyl-Substituted Naphthalenes

Project description:Naphthalene and its alkyl-substituted derivatives are among the most abundant polycyclic aromatic hydrocarbons (PAHs) in environmental and human exposure studies, yet their developmental toxicity and mode of action remain poorly understood due to challenges in testing of semi-volatile compounds. This study developed a vial based high through-put method to effectively assess the activity of naphthalenes and a set of 24 alkyl-substituted naphthalenes. Early life stage zebrafish were exposed to a concentration series of each chemical (0-50 µM) in rotating sealed glass vials to minimize volatilization. Benchmark concentration (BMC50) values were calculated for morphological endpoints and lowest effect levels were determined for behavioral effects. The data were assessed for evidence of a narcotic mode of action using body burden measurements for select chemicals and logKow modeling. Targeted transcriptomics at a single concentration and timepoint as well as in silico molecular docking were conducted to generate mode of action hypothesis. The vial method enabled detection of highly variable developmental toxicity not previously observed using standard 96-well plate exposures. LogKow and body burden were poor predictors of toxicity, suggesting a non-narcotic mode of action. Transcriptomic analysis revealed a limited but notable set of differentially expressed genes, with evidence for the disruption of glucocorticoid signaling pathways. Molecular docking identified potential protein targets (e.g., CYP1A2, NT5E, FOLR1) that may mediate observed effects. This study demonstrates the importance of appropriate exposure methods for semi-volatile compounds, reveals structure-dependent toxicity among alkyl-substituted naphthalenes, and provides a foundation for further mechanistic studies and improved risk assessment of alkyl-substituted PAHs.

2025-05-23 | GSE296410 | GEO

Aspergillus oryzae strain:BP2-1

Project description:Aspergillus oryzae strain:BP2-1 Genome sequencing and assembly

| PRJNA368788 | ENA